777 related articles for article (PubMed ID: 3292571)
61. Maturation of the hypothalamo-pituitary-ovarian axis in adolescent girls.
Lemarchand-Béraud T; Zufferey MM; Reymond M; Rey I
J Clin Endocrinol Metab; 1982 Feb; 54(2):241-6. PubMed ID: 6798063
[TBL] [Abstract][Full Text] [Related]
62. Chronic hyperestrogenemia: lack of positive feedback action on gonadotropin-releasing hormone-induced luteinizing hormone release and dual site of negative feedback action.
Richardson DW; Gordon K; Billiar RB; Little AB
Endocrinology; 1992 Mar; 130(3):1090-6. PubMed ID: 1537275
[TBL] [Abstract][Full Text] [Related]
63. [Steroids and the prediction of ovulation].
Audebert AJ; Emperaire JC; Ruffie A
Contracept Fertil Sex (Paris); 1984 Feb; 12(2):411-9. PubMed ID: 12265829
[TBL] [Abstract][Full Text] [Related]
64. Reduction in pituitary desensitization and prolongation of gonadotropin release by estrogen during continuous administration of gonadotropin-releasing hormone in women: its antagonism by progesterone.
Araki S; Chikazawa K; Motoyama M; Ijima K; Abe N; Tamada T
J Clin Endocrinol Metab; 1985 Mar; 60(3):590-8. PubMed ID: 3919050
[TBL] [Abstract][Full Text] [Related]
65. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
Behre HM; Nashan D; Hubert W; Nieschlag E
J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
[TBL] [Abstract][Full Text] [Related]
66. Failure of estrogen-induced discharge of luteinizing hormone in lactating women.
Baird DT; McNeilly AS; Sawers RS; Sharpe RM
J Clin Endocrinol Metab; 1979 Oct; 49(4):500-6. PubMed ID: 479342
[TBL] [Abstract][Full Text] [Related]
67. Clinical applications of LHRH and its analogues.
Sandow J
Clin Endocrinol (Oxf); 1983 Jun; 18(6):571-92. PubMed ID: 6136347
[TBL] [Abstract][Full Text] [Related]
68. Mode of action of RU 486.
Bygdeman M; Swahn ML; Gemzell-Danielsson K; Svalander P
Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
[TBL] [Abstract][Full Text] [Related]
69. Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception.
Bergquist C; Nillius SJ; Wide L; Lindgren A
Fertil Steril; 1981 Sep; 36(3):339-42. PubMed ID: 6793403
[TBL] [Abstract][Full Text] [Related]
70. Anti-LHRH and anti-pituitary gonadotropin vaccines: their development and clinical applications.
Thau R
Scand J Immunol Suppl; 1992; 11():127-30. PubMed ID: 1514027
[TBL] [Abstract][Full Text] [Related]
71. [Contraception with pure, synthetic progestogens of the norpregnane group, a new approach for the future?].
Rozenbaum H
Contracept Fertil Sex (Paris); 1986 Jun; 14(6):577-81. PubMed ID: 12341096
[TBL] [Abstract][Full Text] [Related]
72. Long-term intranasal luteinizing hormone-releasing hormone agonist treatment for contraception in women.
Bergquist C; Nillius SJ; Wide L
Fertil Steril; 1982 Aug; 38(2):190-3. PubMed ID: 6809500
[TBL] [Abstract][Full Text] [Related]
73. Peptide contraception by inhibition of ovulation with intranasal GnRH superagonist: clinical and metabolic aspects.
Gudmundsson JA; Bergquist C; Nillius SJ
Prog Clin Biol Res; 1986; 225():337-51. PubMed ID: 2947248
[TBL] [Abstract][Full Text] [Related]
74. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
Filicori M; Flamigni C; Campaniello E; Valdiserri A; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A
J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
[TBL] [Abstract][Full Text] [Related]
75. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
[TBL] [Abstract][Full Text] [Related]
76. Acute effects of progesterone and the antiprogestin RU 486 on gonadotropin secretion in the follicular phase of the menstrual cycle.
Permezel JM; Lenton EA; Roberts I; Cooke ID
J Clin Endocrinol Metab; 1989 May; 68(5):960-5. PubMed ID: 2497130
[TBL] [Abstract][Full Text] [Related]
77. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
McCartney CR; Eagleson CA; Marshall JC
Semin Reprod Med; 2002 Nov; 20(4):317-26. PubMed ID: 12536355
[TBL] [Abstract][Full Text] [Related]
78. Gonadotropin releasing hormone analogs for female contraception by inhibition of ovulation.
Nillius SJ
J Steroid Biochem; 1985 Nov; 23(5B):849-54. PubMed ID: 2934581
[TBL] [Abstract][Full Text] [Related]
79. Gonadotropin-releasing hormone and its clinical applications.
Loucopoulos A; Ferin M
Obstet Gynecol Annu; 1984; 13():275-88. PubMed ID: 6326010
[TBL] [Abstract][Full Text] [Related]
80. Inhibition of cyclic gonadotropin secretion by endogenous human prolactin.
Tyson JE; Khojandi M; Huth J; Smith B; Thomas P
Am J Obstet Gynecol; 1975 Feb; 121(3):375-9. PubMed ID: 1115151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
